Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia

Research output: Contribution to journalReviewpeer-review

View graph of relations

Trigeminal neuralgia is a very painful neurological condition with severe, stimulus-evoked, short-lasting stabbing pain attacks in the face. The past decade has offered new insights into trigeminal neuralgia symptomatology, pathophysiology, and treatment, leading to a change in the classification of the condition. An accurate diagnosis is crucial because neuroimaging interpretation and clinical management differ among the various forms of facial pain. MRI using specific sequences should be a part of the diagnostic workup to detect a possible neurovascular contact and exclude secondary causes. Demonstration of a neurovascular contact should not be used to confirm a diagnosis but rather to facilitate surgical decision making. Carbamazepine and oxcarbazepine are drugs of first choice for long-term treatment, whereas microvascular decompression is the first-line surgery in medically refractory patients. Advances in neuroimaging techniques and animal models will provide further insight into the causes of trigeminal neuralgia and its pathophysiology. Development of more efficacious treatment options is highly warranted.

Original languageEnglish
JournalThe Lancet Neurology
Issue number9
Pages (from-to)784-796
Number of pages13
Publication statusPublished - 2020

    Research areas

  • Animals, Anticonvulsants/pharmacology, Carbamazepine/pharmacology, Decompression, Surgical/methods, Disease Management, Humans, Neuroimaging/methods, Oxcarbazepine/pharmacology, Pain Measurement/drug effects, Trigeminal Neuralgia/classification

ID: 60922701